Loren Data's SAM Daily™

FBO DAILY ISSUE OF SEPTEMBER 21, 2012 FBO #3954
DOCUMENT

65 -- Histology Lab-Ventana Consumables - Attachment

Notice Date

9/19/2012
 

Notice Type

Attachment
 

NAICS

325413 — In-Vitro Diagnostic Substance Manufacturing
 

Contracting Office

Department of Veterans Affairs;Network Contracting Office 20;5115 NE 82nd Ave, Suite 102;Vancouver WA 98662
 

ZIP Code

98662
 

Solicitation Number

VA26012Q1686
 

Response Due

9/26/2012
 

Archive Date

10/26/2012
 

Point of Contact

Mona L Nimmo
 

E-Mail Address

immo@va.gov<br
 

Small Business Set-Aside

N/A
 

Description

September 18, 2012 SUBJECT: Combined Synopsis/Solicitation for Commercial Supplies This is a combined synopsis/solicitation for commercial supplies prepared in accordance with the format in Subpart 12.6 and Far Part 13 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. This is a request for competitive quotes, and all offers received prior to September 25, 2012 will be considered by the Government. The solicitation is being issued as Request for Quote # VA260-12-Q-1686. The NAICS Code is 325413. This solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2005-61. Only emailed requests received directly from the requester are acceptable. Evaluation Factors: The Government will award based on Lowest Price Technically Acceptable (LPTA). An award will be made on the basis of the lowest price of quotes meeting the brand names salient characteristic as described in the schedule of items. Description: Various Ventana Histology Immunostainer Reagents and consumables to operate Ventana Instruments. Estimated usage is as follows. Quantity Net as valuesQuantitiesPrice Totals VA MEDICAL CNTR-SEATTLE WA (2481)IHC Detection760-500 - ULTRAVIEW UNIVERSAL DAB DETECTION KIT15 IHC Detection15 IHC Primary Antibodies - VentanaDx790-2951 - ASSY; KIT PACK; PATHWAY C-KIT2 IHC Primary Antibodies - VentanaDx2 IHC Primary Antibodies - Other760-2680 - FITC ANTI-IGG PRIMARY ANTIBODY2 760-2681 - NEXES REAGENT, VENTANA, FITC ANTI-IGA2 760-2682 - FITC ANTI-IGM PRIMARY ANTIBODY2 760-2683 - FITC ANTI-KAPPA PRIMARY ANTIBODY1 760-2684 - FITC ANTI-LAMBDA PRIMARY ANTIBODY1 760-2685 - FITC ANTI-FIBRINOGEN PRIMARY ANTIBODY1 760-2686 - FITC ANTI-C3 PRIMARY ANTIBODY2 760-2688 - FITC ANTI-C1Q PRIMARY ANTIBODY1 760-2699 - FITC ANTI-ALBUMIN PRIMARY ANTIBODY1 760-1029 - CONFIRM NEG. CONTR. RABBIT IG2 760-2014 - NEGATIVE CONTROL MOUSE IG3 760-2504 - CONFIRM ANTI-CD15 (MMA) PAB, IVD2 760-2505 - CONFIRM ANTI-CD45 (LCA) (RP2/18) PRIMARY ANTIBODY2 760-2507 - ANTI-CEA (TF-3H8-1) PAB1 760-2511 - ANTI-CD43 (L60) PRIMARY ANTIBODY2 760-2513 - CONFIRM ANTI-DESMIN (DE-R-11) PAB1 760-2531 - CONFIRM ANTI-CD20 (L26) PAB5 760-2595 - ANTI-KERATIN, PAN (AE1/AE3 & PCK26) PAB3 760-2224 - CELL MARQUE, Cytokeratin 7 (OV-TL 12/30)1 760-2616 - CELL MARQUE, CD232 760-2625 - CELL MARQUE, CD561 760-2631 - CELL MARQUE, CD99,MIC21 760-2635 - CELL MARQUE, CYTOKERATIN 201 760-2636 - CELL MARQUE, CK, 34BETAE122 760-2642 - CELL MARQUE, FACTOR 8-R AG.1 760-2645 - CELL MARQUE, HELICOBACTER PYLORI4 760-2648 - CELL MARQUE, HSV I & II1 760-2659 - CELL MARQUE, MYELOPEROXIDASE1 760-2661 - CELL MARQUE, NEUROFILAMENT1 760-2668 - CELL MARQUE, SYNAPTOPHYSIN1 760-2705 - NEXES REAGENT, CELL MARQUE, CD102 760-4240 - Cell Marque, bcl-2 (124)2 760-4241 - Cell Marque, bcl-62 760-4244 - Cell Marque, CD1a (MTB1)1 760-4246 - Cell Marque, CD31 (1A10)1 760-4248 - CD-138 (B-A38)4 760-4257 - Cell Marque, Glycophorin A1 760-4259 - Cell Marque, EMA (E29)1 760-4264 - Cell Marque, MLH-1 (G16B-728)1 760-4265 - Cell Marque, MSH-21 760-4270 - Cell Marque, PAX-5 (24)2 760-4271 - Cell Marque, PSA (ER-PR8)1 760-4276 - Cell Marque, Tryptase (G3)1 760-4280 - CELL MARQUE, CD5 (SP19)2 760-4282 - Cell Marque, Cyclin D1 (SP4)1 760-4345 - Glial Fibrillary Acidic Protein (EP672Y) Primary Antibody1 760-4380 - CDX-2 (EPR2764Y) PAb, Cell Marque1 790-2914 - CONFIRM ANTI-S100 (4C4.9) PRIMARY ANTIBODY2 790-2917 - CONFIRM ANTI-VIMENTIN (V9) PRIMARY ANTIBODY2 790-2918 - CONFIRM ANTI-ALK1 (ALK01)1 790-2926 - CONFIRM ANTI-CD30 (CLONE BER-H2) PRIMARY ANTIBODY2 790-2927 - CONFIRM ANTI-CD34 (QBEND/10) PRIMARY ANTIBODY2 790-2931 - CONFIRM ANTI-CD68 (KP-1) PRIMARY ANTIBODY2 790-2990 - CONFIRM MART-1/MELAN A (A103) PRIMARY ANTIBODY1 790-4341 - CONFIRM ANTI-CD3 (2GV6) RABBIT MONOCLONAL PRIMARY ANTIBODY4 IHC Primary Antibodies - Other92 IHC Ancillaries760-080 - AMPLIFICATION KIT, CE6 760-2018 - PROTEASE 12 760-2021 - HEMATOXYLIN15 760-2037 - BLUING REAGENT16 783-2855 - Prep Kit #5, BenchMark1 771-751 - NEXES REAGENT DISPENSER CARD, OPTION #110 1358501 - LABEL, BLANK, FLAP, ROLL (540)8 IHC Ancillaries58 BenchMark Ancillaries650-010 - LCS48 950-300 - REACTION BUFFER CONCENTRATE (10X)25 950-124 - CELL CONDITIONING SOLUTION, CC1, 2L9 950-102 - 10X EZ PREP SOLUTION; 2L11 BenchMark Ancillaries93 Breast Business790-4286 - CONFIRM ANTI-KI-67 (30-9) RABBIT MONOCLONAL PRIMARY ANTIBODY3 Breast Business3 IHC 263 VA MEDICAL CNTR-SEATTLE WA (2481) 263 Period of Performance: October 1, 2012 through September 30, 2013. The supplies and reagents used for this request are used in the Ventana Immunostainer Benchmark XT instrument. The immunostain process applies antibodies to tissue during the immunhistochemistry application. It defines tumor and other situations within cells of Veteran patients. This process is necessary to determine illness or disease. The offeror shall provide documentation detailing the specifications of the product being offered as to how it meets the salient characteristics. To the maximum extent practicable, offerors are encouraged to respond to this solicitation using pre-existing materials (such as brochures, catalogs, marketing documents) rather than creating new documents. Offerors shall annotate the salient characteristics listed above to indicate the location of the relevant information used to meet the specification (document name and page number). The VISN 20 Network Contracting Activity intends to solicit quotes and award a firm fixed price contract under full and open competition. The following clauses and provisions apply to this solicitation: 52.211-6 Brand Name or Equal; 52.212-1 Instructions to Offerors-Commercial; 52.212-2 Evaluation-Commercial Items; 52.212-3 Offeror Representations and Certifications-Commercial Items. 52.212-4, Contract Terms and Conditions-Commercial Items; 52.212-5, Contract Terms and Conditions Required To Implement Statutes or Executive Orders-Commercial Items, paragraph (a) and the following clauses in paragraph (b): 52.204-10 Reporting Executive Compensation & First-Tier Subcontract Award; 52.209-10 Prohibition on Contracting with Inverted Domestic Corporations; 52.219-28 Post Award Small business Program Representation; 52.222-3 Convict Labor; 52.222-19 Child Labor-Cooperation with Authorities and Remedies; 52.222-21, Prohibition of Segregated Facilities; 52.222-26 Equal Opportunity; 52.222-35 Equal Opportunity for Veterans; 52.222-36 Affirmative Action for Workers with Disabilities; 52.222-37 Employments Reports on Veterans; 52.223-18 Contractor Policy to Ban Text Messaging while Driving; 52.225-3 Buy American Act-Free Trade Agreement-Israeli Trade Act (iii) Alternate III; 52.225-13 Restrictions on Certain Foreign Purchases; and 52.232-34 Payment by Electronic Funds Transfer. 852.203-70 Commercial Advertising; 852.211-73 Brand Name or Equal; 852.237-70 Contractor responsibilities, 852.246-70 Guarantee, 852.246-71 Inspection; and 852.273-76 Electronic Invoice Submission. Offerors are to submit pricing to Department of Veterans Affairs Network Contracting Office 20 (NCO 20). Process of determining contract award: award will be to the lowest-priced responsive, responsible bidder who can provide the item. This information should be specific, concise, and complete and provide sufficient information to demonstrate the offeror's capacity to meet or exceed the requirements of the contract. The information required in provisions 52.212-1, 52.212-2, a completed copy of provisions 52.212-3, Offeror Representations and Certifications, Commercial Items. The full text of the referenced FAR clauses may be accessed electronically at https://www.acquisition.gov/far/. Quotes, including price and technical data for equal items, must be received by 5:00 PM, September 24, 2012 PT. Quotes shall be submitted via email to mona.nimmo@va.gov.
 

Web Link

FBO.gov Permalink
(https://www.fbo.gov/notices/da0de0ad1769b4b9fda425f6f536cad4)
 

Document(s)

Attachment
 

File Name: VA260-12-Q-1686 VA260-12-Q-1686.docx (https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=480790&FileName=VA260-12-Q-1686-000.docx)

Link: https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=480790&FileName=VA260-12-Q-1686-000.docx

 

Note: If links are broken, refer to Point of Contact above or contact the FBO Help Desk at 877-472-3779.
 

Place of Performance

Address: Seattle VA-Histology Lab;Seattle, WA

Zip Code: 98108-1597
 

Record

SN02890852-W 20120921/120920002529-da0de0ad1769b4b9fda425f6f536cad4 (fbodaily.com)
 

Source

FedBizOpps Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |